Peroxisome proliferator-activated receptor-α activation inhibits langerhans cell function

被引:39
作者
Dubrac, Sandrine
Stoitzner, Patrizia
Pirkebner, Daniela
Elentner, Andreas
Schoonjans, Kristina
Auwerx, Johan
Saeland, Sem
Hengster, Paul
Fritsch, Peter
Romani, Nikolaus
Schmuth, Matthias
机构
[1] Innsbruck Med Univ, Dept Dermatol, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Kompetenzzentrum Med Tirol Zentraler Informat Die, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria
[3] Inst Genet & Biol Cellulaire & Mol, Illkirch Graffenstaden, France
[4] DermImmune, Lyon, France
基金
奥地利科学基金会;
关键词
D O I
10.4049/jimmunol.178.7.4362
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epidermal Langerhans cells (LC) play a pivotal role in initiating and maintaining primary immune responses in the skin. In the present study, we asked whether peroxisome proliferator-activated receptor-alpha (PPAR alpha) activation modulates LC function. Our results show that PPAR alpha is expressed in immature LC and is down-regulated in mature LC suggesting that an early decrease of PPARa expression in LC may allow them to mature after contact with an Ag. We further show that pharmacologic PPAR alpha activation inhibits LC maturation, migratory capacity, cytokine expression, and the ability to drive T cell proliferation. Moreover, PPARa activation inhibits NF-kappa B but not stress-activated protein kinase/JNK, p38MAPK, and ERK1/2. In conclusion, PPAR alpha activation by endogenous ligands may provide a molecular signal that allows LC to remain in an immature state within the epidermis for extended periods of time despite minor environmental stimuli.
引用
收藏
页码:4362 / 4372
页数:11
相关论文
共 56 条
[1]   Peroxisome proliferator-activated receptor γ inhibits the migration of dendritic cells:: Consequences for the immune response [J].
Angeli, W ;
Hammad, H ;
Staels, B ;
Capron, M ;
Lambrecht, BN ;
Trottein, F .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5295-5301
[2]   PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways [J].
Appel, S ;
Mirakaj, V ;
Bringmann, A ;
Weck, MM ;
Grünebach, F ;
Brossart, P .
BLOOD, 2005, 106 (12) :3888-3894
[3]   PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[4]   Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation [J].
Blanquart, C ;
Barbier, O ;
Fruchart, JC ;
Staels, B ;
Glineur, C .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) :267-273
[5]   Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-α [J].
Boislève, F ;
Kerdine-Römer, S ;
Pallardy, M .
TOXICOLOGY, 2005, 206 (02) :233-244
[6]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[7]   Nuclear receptors and lipid physiology: Opening the X-files [J].
Chawla, A ;
Repa, JJ ;
Evans, RM ;
Mangelsdorf, DJ .
SCIENCE, 2001, 294 (5548) :1866-1870
[8]   Conjugated linoleic acid promotes human adipocyte insulin resistance through NFκB-dependent cytokine production [J].
Chung, SK ;
Brown, JM ;
Provo, JN ;
Hopkins, R ;
McIntosh, MK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (46) :38445-38456
[9]   IL-1β-induced Langerhans' cell migration and TNF-α production in human skin:: regulation by lactoferrin [J].
Cumberbatch, M ;
Bhushan, M ;
Dearman, RJ ;
Kimber, I ;
Griffiths, CEM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (02) :352-359
[10]   Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration [J].
Cumberbatch, M ;
Dearman, RJ ;
Kimber, I .
IMMUNOLOGY, 1997, 92 (03) :388-395